Rafferty Asset Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
VCM
VPM
N
Rafferty Asset Management's ALT Position: Q1 2026 in Review
Rafferty Asset Management increased its Altimmune (ALT) stake by 18% in Q1 2026, buying an estimated $151K and bringing the position to 231,271 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #843.
Rafferty Asset Management first reported a position in ALT in Q1 2021 and has held it in 16 quarters since. The position peaked at $9.85M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.
- Rafferty Asset Management held 231,271 shares of Altimmune worth $712K as of Q1 2026.
- Rafferty Asset Management bought 35,505 Altimmune shares in Q1 2026, an estimated $151K.
- Altimmune made up ﹤0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #843 holding.
- Rafferty Asset Management first reported a position in Altimmune in Q1 2021 and has held it in 16 quarters since.
- Rafferty Asset Management's Altimmune position peaked at $9.85M in Q4 2022.
- 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.